Vouliez-vous dire
region

Résultats de la recherche - 6 results

Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study.

and territories with data. Model outcomes were extracted from 2015 to 2030 to calculate population-weighted regional averages, which were used for countries or territories without data. Regional and ...

Challenges to Differentiate Hepatitis C Genotype 1 and 6: Results from A Field-Study in Cambodia.

instructions, it could not be excluded that it concerned a genotype 6 infection as the core region line patterns on the Versant test strip were unavailable, inconclusive or atypical. Upon sequencing, seven of ...

Low hepatitis C prevalence in Belgium: implications for treatment reimbursement and scale up.

to estimate the budgetary impact of reimbursement of direct-acting antivirals (DAA s). In Belgium, the restricted reimbursement criteria are mainly guided by regional seroprevalence estimates of 0.87% ...

Distribution of HCV genotypes in Belgium from 2008 to 2015.

possible impact of migration from endemic regions and prior to the increasing use of highly potent direct-acting antiviral (DAA) agents. Health Topics:  Hepatitis A, B, C, D en E Hepatitis A, B, C, D and ...

Development and characterization of a human monoclonal antibody targeting the N-terminal region of hepatitis C virus envelope glycoprotein E1.

reactivity of mAb A6 to full-length HCV E1E2 of genotypes 1a, 1b and 2a. Epitope mapping identified a region spanning amino acids 230-239 within the N-terminal region of E1 as critical for binding. Antibody ...

Stable HEV IgG seroprevalence in Belgium between 2006 and 2014.

trends in birth cohort-specific HEV seroprevalence and regional differences in Belgium. HEV IgG seroprevalence was analysed on national serum banks (1579 and 2087 samples for 2006 and 2014, respectively. ...

QR code

QR code for this page URL